The start of the 2026 academic year marks a turning point in several areas of medicine, with institutional positions that directly modify clinical practices. Between the ethical regulation of artificial intelligence in research, new vaccination strategies, and developments in prenatal screening, we are witnessing changes that go beyond mere announcements.
Ethical Regulation of AI in Medical Research: WHO Framework of September 2026
The report published by the World Health Organization on September 21, 2026, sets a milestone that clinical research teams can no longer ignore. The document explicitly targets the risks of bias, inequity, and infringement of participants’ rights in protocols integrating artificial intelligence tools.
The central recommendation focuses on strengthening the role of ethics committees, as well as the involvement of funders, scientific journals, and regulatory authorities. This is no longer a mere statement of intent: the WHO calls for a systematic evaluation of the algorithms used in the collection and analysis of health data.
Specifically, sponsors of clinical trials relying on predictive models for patient selection or outcome analysis will need to document the sources of training data, performance metrics by subgroup, and bias correction mechanisms. Peer-reviewed journals that publish news on santeinfo.net are already relaying these requirements in their updated editorial guidelines.
For hospital teams, this means an increased documentation burden prior to submissions. We recommend integrating a data ethics specialist from the protocol design phase, rather than downstream as is still often the case.
Pneumococcal Vaccination Strategy: Reevaluation by the HAS
The High Authority of Health conducted a comprehensive reevaluation of the vaccination strategy against pneumococcal infections in September 2026. This update is not cosmetic: it reflects the arrival of vaccines offering broader protection and the change in circulating serotypes.
The gradual replacement of serotypes covered by older vaccine formulations with non-vaccine serotypes had been anticipated by epidemiologists. The HAS is therefore adjusting the schedule to take this real microbiological dynamic into account, rather than a mere commercial expansion of the range.
Impact on Prescriptions in General Medicine
General practitioners must update their primary vaccination and booster schedules. Immunocompromised patients, residents of nursing homes, and individuals with chronic respiratory diseases are the first to be affected by these new recommendations.
- Check the serotype coverage of the vaccine administered against the updated HAS recommendations
- Adapt the vaccination schedule for patients already partially vaccinated with older formulations
- Systematically document the pneumococcal vaccination status in the shared medical record
CMV Screening During Pregnancy: Post-Diagnosis Management
The HAS published specific recommendations in September 2026 on management after cytomegalovirus screening during pregnancy. This aspect extends the framework of the screening itself by structuring the support and follow-up of the affected women.
Having a formalized care pathway after a positive result changes the situation for practitioners who, until now, navigated with heterogeneous protocols depending on the maternity units.
Structured Follow-Up Pathway
The recommendations specify the steps for enhanced ultrasound monitoring, criteria for referral to a prenatal diagnostic center, and methods for informing patients. The goal is to avoid both anxiety-inducing overdiagnosis and under-monitoring that exposes patients to undetected neonatal complications.
Flu Vaccination for Healthcare Workers: Towards a Targeted Obligation
Among the most debated orientations this academic year, the HAS recommends a mandatory flu vaccination for healthcare professionals in contact with vulnerable individuals. Priority is given to nursing homes and long-term care units.
This recommendation contrasts with the incentive-based approach that has prevailed until now. Vaccination coverage rates for flu among healthcare workers remain notoriously insufficient, and epidemiological data show a direct impact on the morbidity and mortality of elderly residents.
The operational implementation raises questions of occupational medicine and human resource management that facility management will need to anticipate. The legal framework for such an obligation remains to be clarified through regulatory means.
All these developments outline a landscape where regulation and oversight of practices take precedence over raw innovation. Healthcare professionals who integrate these recommendations into their daily organization now will save considerable time when the regulatory texts follow.
